EyePoint Pharmaceuticals, Inc. announced the appointment of leading global ophthalmologists to its Scientific Advisory Board (SAB), co-chaired by Carl Regillo M.D., FACS, Chief of the Retina Service at Wills Eye Hospital and Charles Wykoff, M.D., Ph.D., Director of Research of Retina Consultants of Texas. The SAB additions include Usha Chakravarthy, M.B.B.S., Ph.D.; Allen Ho, M.D. FACS FASRS, and Frank Holz, M.D., F.E.B.O., F.A.R.V.O.
Usha Chakravarthy, M.B.B.S., Ph.D. is an Honorary and Emerita Professor of Ophthalmology and Vision Sciences at the Queen?s University of Belfast. She is recognized internationally for her work on age-related macular degeneration (AMD) and diabetic retinopathy. Dr. Chakravarthy has authored or co-authored over 400 publications, and she is invited to lecture in the UK and abroad. She has been involved in many of the major international retina clinical trials as well as co-authored Cochrane Review articles and guidelines for the Royal College of Ophthalmologists on the treatment of AMD. Dr. Chakravarthy has been the recipient of many prestigious awards including the title of Commander in the Most Excellent Order of the British Empire for clinical services to ophthalmology and research. She holds a Ph.D. from Queen?s University of Belfast and an M.B.B.S. from the University of Madras.
Allen Ho, M.D. FACS FASRS is Attending Surgeon, Director of Retina Research and Co-Director of the Retina Service of Wills Eye Hospital and Professor of Ophthalmology at Thomas Jefferson University. He has deep experience in translational clinical research and maintains special interests in macular diseases, diabetic retinopathy, surgical retinal diseases and clinical trials, investigating new treatments for vitreoretinal diseases. Dr. Ho has authored over 300 peer reviewed publications and several textbooks. He has been a principal investigator on numerous major clinical trials developing new medical and surgical treatments for retinal disorders. Dr. Ho is the recipient of numerous awards including from the American Academy of Ophthalmology, multiple retina societies and the American Diabetes Association, and he is a perennial awardee of national Castle Connolly awards. He was also named in the Ophthalmologist Power List of the top 100 most influential ophthalmologists in the world. Dr. Ho holds an M.D. from Columbia University College of Physicians and Surgeons and a B.A. from Cornell University. Frank Holz, M.D., F.E.B.O., F.A.R.V.O. is a professor and chairman of the Department of Ophthalmology at the University of Bonn in Germany. He founded the Medical Imaging Center Bonn (MIB), the GRADE Reading Center Bonn and was a co-founder of the Priority Program AMD of the German Research Council. He has published over 600 articles in peer-reviewed journals and has authored or co-authored more than 20 book chapters on age-related macular degeneration, medical retina and retinal imaging. Dr. Holz is the recipient of multiple local, national and international awards including the Pro Retina Macular Degeneration Research Award, the Leonhard-Klein Award for Ocular Surgery, the Alcon Research Institute (ARI) Award, the Senior Achievement Award of the AAO and the Jules Gonin Award. He is a Board Member of the German Ophthalmological Society, and of the Club Jules Gonin and is past president of EURETINA. Dr. Holz trained at the University of Heidelberg, the University of Chicago Pritzker School of Medicine and completed a fellowship at Moorfields Eye Hospital, London.